| 書目名稱 | Cancer Immunology | | 副標題 | Bench to Bedside Imm | | 編輯 | Nima Rezaei | | 視頻video | http://file.papertrans.cn/222/221129/221129.mp4 | | 概述 | Describes in detail novel strategies in cancer immunotherapy and targeting of tumor immunosuppression.Provides a bench to bedside approach to the immunology of cancers, with a focus on clinical aspect | | 圖書封面 |  | | 描述 | .This translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy. .The book is published as part of the three-volume Springer series .Cancer Immunology., which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and cancer immunotherapy for organ-specific tumors. .Cancer Immunology: Bench to Bedside Immunotherapy of Cancers. .will be of special value to clinical immunologists, hematologists, and oncologists...?. | | 出版日期 | Book 2021Latest edition | | 關鍵詞 | Cancer immunotherapy; Translational medicine; Prognostic biomarkers; Tumor immunosuppression; Gene thera | | 版次 | 2 | | doi | https://doi.org/10.1007/978-3-030-50287-4 | | isbn_softcover | 978-3-030-50289-8 | | isbn_ebook | 978-3-030-50287-4 | | copyright | Springer Nature Switzerland AG 2021 |
The information of publication is updating
|
|